Showing results (1-10 of 259) with videos related to
Sort By:
Pageof 26
Current Drug Targets|October 5, 2010
Sub-macular surgery: is still an option for age-related macular degeneration?Mario R Romano, Xavier Valldeperas, Paolo Vinciguerra, et al.Case Reports in Ophthalmology|August 26, 2010
Bilateral Keratectasia 34 Years after Corneal TransplantXavier Valldeperas, Martina Angi, Vito Romano, et al.International Ophthalmology|January 24, 2009
Macular sensitivity changes for detection of chloroquine toxicity in asymptomatic patientMartina Angi, Vito Romano, Xavier Valldeperas, et al.Retina (Philadelphia, Pa.)|March 10, 2011
Twenty-three-gauge pars plana vitrectomy, Densiron-68, and 360° endolaser versus combined 20-gauge pars plana vitrectomy, scleral buckle, and SF6 for pseudophakic retinal detachment with inferior retinal breaksMario R Romano, Martina Angi, Xavier Valldeperas, et al.Clinical Ophthalmology (Auckland, N.Z.)|December 24, 2010
Intraocular pressure changes following the use of silicone oil or Densiron 68 as endotamponade in pars plana vitrectomyMario R Romano, Martina Angi, Vito Romano, et al.Indian Journal of Ophthalmology|January 6, 2012
Primary 23-gauge sutureless vitrectomy for rhegmatogenous retinal detachmentMario R Romano, Ronald Das, Carl Groenwald, et al.Mediators of Inflammation|December 11, 2013
Inflammatory mechanisms of idiopathic epiretinal membrane formationMalav Joshi, Shivi Agrawal, John Byron ChristoforidisMediators of Inflammation|December 19, 2013
Systemic treatments for noninfectious vitreous inflammationAngela Jiang, Jillian Wang, Malav Joshi, et al.Biomedical Optics Express|July 16, 2026
Two-photon imaging microscopy of non-stained human epiretinal membranesJuan M Bueno, Xavier ValldeperasPageof 26